8-K: BIO-key International Reports 18% Revenue Increase in Q3 2024, Reduces Net Loss and Improves Cash Position

BIO-key International announced an 18% increase in revenue to $2.1 million for Q3 2024, alongside a reduced net loss and improved cash position.

Summary

• BIO-key International reported its financial results for the third quarter of 2024, showing an 18% increase in revenue to $2.1 million compared to $1.8 million in Q3 2023.
• The company's gross profit significantly improved to $1.7 million with a 78.3% gross margin, up from $0.3 million and 18.7% in the same period last year.
• This improvement was driven by a $0.5 million increase in license revenue from expanded software deployments by long-term customers and a $1 million hardware reserve taken in the prior year.
• Operating expenses were reduced by $46,000 compared to Q3 2023, due to proactive reductions in administration, sales personnel costs, and marketing expenses.
• BIO-key's net loss for Q3 2024 was $0.7 million, a significant improvement from the $1.8 million net loss in Q3 2023.
• The company's cash position improved to $1.8 million at the end of Q3 2024, compared to $0.5 million at the end of 2023, due to a $1.9 million capital raise through a warrant inducement agreement.
• For the first nine months of 2024, revenues were $5.5 million compared to $5.9 million in the same period of 2023, with increased license fees and hardware revenue offset by lower service revenues.
• The net loss for the first nine months of 2024 was reduced to $2.9 million, compared to a net loss of $6.1 million in the first nine months of 2023.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with significant improvements in revenue, gross profit, and net loss. The company's cash position has also improved. However, there are still risks and challenges, including the need to achieve profitability and the potential for stock delisting if certain equity requirements are not met. The sentiment is therefore cautiously optimistic.

Positives

• The company experienced a significant increase in revenue, driven by higher license fees and hardware sales.
• Gross profit margins improved substantially due to a higher proportion of high-margin license revenue and lower deployment costs.
• Operating expenses were reduced, reflecting cost-cutting measures.
• The net loss was significantly reduced compared to the same quarter last year.
• The company's cash position improved due to a capital raise.
• BIO-key secured significant new orders and expanded deployments with existing customers.
• BIO-key's technology is being adopted by major clients, including a large financial institution and a defense ministry.

Negatives

• Service revenues declined due to the loss of a large recurring service agreement and a customization customer.
• Cash used in operating activities was $2.4 million through the first nine months of 2024.
• Research, development and engineering expenses increased by $122,000 due to increased personnel costs.

Risks

• The company has a history of losses and limited revenue.
• BIO-key's ability to raise additional capital to satisfy working capital needs is a risk.
• The company's ability to continue as a going concern is a risk.
• There are risks associated with protecting intellectual property.
• The company faces competition in the biometric technology industry.
• Market acceptance of biometric products and BIO-key's products under development is a risk.
• The company's ability to convert sales opportunities to customer contracts is a risk.
• There are risks associated with expanding into foreign markets.
• The company faces risks related to the integration of Swivel Secure.
• Fluctuations in foreign currency exchange rates pose a risk.
• Delays in product development are a risk.
• The company faces commercial, reputational and regulatory risks due to the restatement of financial statements.
• The company's common stock could be delisted from the Nasdaq Capital Market if it fails to increase its stockholders equity to at least $2.5 million.
• There is a risk of disruption to the business if the company is unable to remediate material weaknesses in internal controls over financial reporting.

Future Outlook

The company expects full year 2024 revenues to meet or exceed the $7.75 million achieved in 2023 and continues to pursue opportunities to lower overhead and variable costs, as it progresses the business toward positive operating cash flow and profitability in the coming quarters. They are also seeking strategic opportunities to leverage their core strengths.

Management Comments

• BIO-key CEO, Mike DePasquale, stated that the company had a very productive third quarter, with revenue increasing 18% year-over-year and $1M compared to Q224.
• He noted that Q324 revenues reflected strength in orders from existing customers who are expanding their deployment of BIO-key solutions.
• He highlighted a large-scale adoption of their technology by a long-time foreign financial services customer.
• He mentioned that the company expects performance to vary on a quarter-to-quarter basis as they build a growing base of high-margin, annually recurring revenue streams.
• He stated that the company continues to seek potential strategic opportunities that can leverage their core strengths and business platform to create value for their shareholders.

Industry Context

The announcement reflects a growing trend in the cybersecurity industry towards biometric authentication solutions, particularly in the Identity and Access Management (IAM) sector. The company's focus on passwordless, phoneless, and token-less authentication aligns with the industry's move towards more secure and user-friendly access control methods. The adoption of BIO-key's technology by a major financial institution and a defense ministry highlights the increasing demand for biometric solutions in both the private and public sectors.

Comparison to Industry Standards

• BIO-key's 78.3% gross margin in Q3 2024 is significantly higher than many software and hardware companies, indicating a strong pricing strategy and efficient cost management, especially when compared to companies with lower margins in the 40-60% range.
• The 18% revenue growth is a positive sign, but it is important to compare this to other companies in the IAM and cybersecurity space. For example, companies like Okta and Ping Identity have shown higher growth rates in the past, but they also operate at a larger scale.
• The reduction in net loss is a positive trend, but BIO-key still needs to achieve profitability. Companies like CrowdStrike and Zscaler, while operating in a different segment of cybersecurity, have demonstrated the ability to achieve profitability at scale.
• The $1.9 million raised through warrant inducement is a relatively small amount compared to the capital raises of larger competitors, which often raise tens or hundreds of millions of dollars in funding rounds.
• The large biometric deployment with the financial services customer is a significant win for BIO-key, and it is important to compare this to other large-scale biometric deployments in the industry. For example, government ID programs and large-scale access control systems often involve millions of users, and BIO-key's deployment is comparable in scale.

Stakeholder Impact

• Shareholders will benefit from the improved financial performance and increased cash position.
• Employees may benefit from the company's growth and potential for future success.
• Customers will benefit from the company's innovative biometric solutions.
• Suppliers may benefit from increased business with BIO-key.
• Creditors may have increased confidence in the company's ability to repay debts.

Next Steps

• BIO-key will host an investor call on November 15th at 10:00 am ET.
• The company intends to publish a detailed whitepaper on the large-scale biometric deployment with the financial services customer.
• BIO-key will continue to pursue opportunities to lower overhead and variable costs.
• The company will continue to seek potential strategic opportunities to leverage its core strengths.

Key Dates

Keywords

biometrics, identity access management, IAM, authentication, cybersecurity, software licenses, hardware sales, financial results, revenue, net loss, gross profit, warrant inducement, cash position